Federal contract award
HT942524P0103
HUMAN MONOCLONAL ANTIBODY DEVELOPMENT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | B537 — Medical and Health Studies |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $120.0K |
| Current contract value | $120.0K |
| Potential contract value / ceiling | $180.0K |
| Start date | Sep 6, 2024 |
| Current end date | Jun 24, 2026 |
| Potential end date | Jun 24, 2026 |
| Latest award activity | Apr 8, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 8, 2026 | P00004 | $0 | HUMAN MONOCLONAL ANTIBODY DEVELOPMENT |
| Mar 11, 2026 | P00003 | $0 | HUMAN MONOCLONAL ANTIBODY DEVELOPMENT |
| Jun 25, 2025 | P00002 | $40.0K | HUMAN MONOCLONAL ANTIBODY (MAB) ANALYSIS |
| Jun 5, 2025 | P00001 | $-40.0K | HUMAN MONOCLONAL ANTIBODY (MAB) TESTING |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.